News
ALT5 Sigma Corporation (the “Company” or “ALT5”) (NASDAQ:ALTS)(FRA:5AR1), a fintech, providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, ...
Orionis Biosciences Inc. is sticking with Genentech Inc. in a second deal to discover small-molecule monovalent glue therapies for treating cancer. Privately held Orionis is getting $105 million up ...
The Swiss pharma has inked several collaborations in this field, suggesting it sees the approach as promising to rid the body ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results